Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Inactivation of Bap1 Cooperates with Losses of Nf2 and Cdkn2a to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse Models.

Kukuyan AM, Sementino E, Kadariya Y, Menges CW, Cheung M, Tan Y, Cai KQ, Slifker MJ, Peri S, Klein-Szanto AJ, Rauscher FJ, Testa JR.

Cancer Res. 2019 May 31. pii: canres.4093.2019. doi: 10.1158/0008-5472.CAN-18-4093. [Epub ahead of print]

PMID:
31151962
2.

Genomic signature of parity in the breast of premenopausal women.

Santucci-Pereira J, Zeleniuch-Jacquotte A, Afanasyeva Y, Zhong H, Slifker M, Peri S, Ross EA, López de Cicco R, Zhai Y, Nguyen T, Sheriff F, Russo IH, Su Y, Arslan AA, Bordas P, Lenner P, Åhman J, Landström Eriksson AS, Johansson R, Hallmans G, Toniolo P, Russo J.

Breast Cancer Res. 2019 Mar 28;21(1):46. doi: 10.1186/s13058-019-1128-x.

3.

Chemotherapy resistance-associated epithelial to endothelial transition in gastric cancer.

4° JOINT MEETING OF PATHOLOGY AND LABORATORY MEDICINE SIPMET–SIPMEL - SECOND JOINT MEETING IN COLLABORATION WITH ASIP–AMP–UEMS–WASPALM - 4° SIPMEL NATIONAL CONGRESS - 34° SIPMET NATIONAL CONGRESS - 4° CONGRESS OF PATHOLOGY AND LABORATORY MEDICINE, Peri S, Biagioni A, Cianchi F, Skalamera I, Staderini F, Schiavone N, Papucci L, Magnelli L.

J Biol Regul Homeost Agents. 2018 Jul-Aug;32(4 Suppl. 1):30. No abstract available.

PMID:
30761866
4.

Functional Conservation of a Developmental Switch in Mammals since the Jurassic Age.

Mookerjee-Basu J, Hua X, Ge L, Nicolas E, Li Q, Czyzewicz P, Zhongping D, Peri S, FuxmanBass JI, Walhout AJM, Kappes DJ.

Mol Biol Evol. 2019 Jan 1;36(1):39-53. doi: 10.1093/molbev/msy191.

PMID:
30295892
5.

Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogramming.

Olagnier D, Brandtoft AM, Gunderstofte C, Villadsen NL, Krapp C, Thielke AL, Laustsen A, Peri S, Hansen AL, Bonefeld L, Thyrsted J, Bruun V, Iversen MB, Lin L, Artegoitia VM, Su C, Yang L, Lin R, Balachandran S, Luo Y, Nyegaard M, Marrero B, Goldbach-Mansky R, Motwani M, Ryan DG, Fitzgerald KA, O'Neill LA, Hollensen AK, Damgaard CK, de Paoli FV, Bertram HC, Jakobsen MR, Poulsen TB, Holm CK.

Nat Commun. 2018 Aug 29;9(1):3506. doi: 10.1038/s41467-018-05861-7.

6.

Self-induced back action actuated nanopore electrophoresis (SANE).

Raza MU, Peri SSS, Ma LC, Iqbal SM, Alexandrakis G.

Nanotechnology. 2018 Oct 26;29(43):435501. doi: 10.1088/1361-6528/aad7d1. Epub 2018 Aug 3.

PMID:
30073973
7.

Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas.

Sementino E, Menges CW, Kadariya Y, Peri S, Xu J, Liu Z, Wilkes RG, Cai KQ, Rauscher FJ 3rd, Klein-Szanto AJ, Testa JR.

J Cell Physiol. 2018 Nov;233(11):8952-8961. doi: 10.1002/jcp.26830. Epub 2018 Jun 15.

PMID:
29904909
8.

Bioactive Compounds from Posidonia oceanica (L.) Delile Impair Malignant Cell Migration through Autophagy Modulation.

Leri M, Ramazzotti M, Vasarri M, Peri S, Barletta E, Pretti C, Degl'Innocenti D.

Mar Drugs. 2018 Apr 21;16(4). pii: E137. doi: 10.3390/md16040137.

9.

Community Oncologists' Decision-Making for Treatment of Older Patients With Cancer.

Mohile SG, Magnuson A, Pandya C, Velarde C, Duberstein P, Hurria A, Loh KP, Wells M, Plumb S, Gilmore N, Flannery M, Wittink M, Epstein R, Heckler CE, Janelsins M, Mustian K, Hopkins JO, Liu J, Peri S, Dale W.

J Natl Compr Canc Netw. 2018 Mar;16(3):301-309. doi: 10.6004/jnccn.2017.7047.

10.

Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR Signaling.

Matthew EM, Yang Z, Peri S, Andrake M, Dunbrack R, Ross E, El-Deiry WS.

Neoplasia. 2018 Mar;20(3):244-255. doi: 10.1016/j.neo.2018.01.004. Epub 2018 Feb 12.

11.

Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma.

Gordon RE, Zhang L, Peri S, Kuo YM, Du F, Egleston BL, Ng JMY, Andrews AJ, Astsaturov I, Curran T, Yang ZJ.

Clin Cancer Res. 2018 Mar 15;24(6):1375-1388. doi: 10.1158/1078-0432.CCR-17-2923. Epub 2018 Feb 6.

12.

Plasmatic carbonic anhydrase IX as a diagnostic marker for clear cell renal cell carcinoma.

Lucarini L, Magnelli L, Schiavone N, Crisci A, Innocenti A, Puccetti L, Cianchi F, Peri S, Supuran CT, Papucci L, Masini E.

J Enzyme Inhib Med Chem. 2018 Dec;33(1):234-240. doi: 10.1080/14756366.2017.1411350.

PMID:
29251173
13.

Phylogenetic Distribution of CMP-Neu5Ac Hydroxylase (CMAH), the Enzyme Synthetizing the Proinflammatory Human Xenoantigen Neu5Gc.

Peri S, Kulkarni A, Feyertag F, Berninsone PM, Alvarez-Ponce D.

Genome Biol Evol. 2018 Jan 1;10(1):207-219. doi: 10.1093/gbe/evx251.

14.

NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis.

Peri S, Izumchenko E, Schubert AD, Slifker MJ, Ruth K, Serebriiskii IG, Guo T, Burtness BA, Mehra R, Ross EA, Sidransky D, Golemis EA.

Nat Commun. 2017 Nov 24;8(1):1772. doi: 10.1038/s41467-017-01877-7.

15.

Investigation of multiphase multicomponent aerosol flow dictating pMDI-spacer interactions.

Sarkar S, Peri SP, Chaudhuri B.

Int J Pharm. 2017 Aug 30;529(1-2):264-274. doi: 10.1016/j.ijpharm.2017.07.005. Epub 2017 Jul 4.

PMID:
28684363
16.

Evidence and Limits of Universal Topological Surface Segregation of Cyclic Polymers.

He Q, Wang SF, Hu R, Akgun B, Tormey C, Peri S, Wu DT, Foster MD.

Phys Rev Lett. 2017 Apr 21;118(16):167801. doi: 10.1103/PhysRevLett.118.167801. Epub 2017 Apr 21.

PMID:
28474912
17.

The homeoprotein Dlx5 drives murine T-cell lymphomagenesis by directly transactivating Notch and upregulating Akt signaling.

Tan Y, Sementino E, Xu J, Pei J, Liu Z, Ito TK, Cai KQ, Peri S, Klein-Szanto AJ, Wiest DL, Testa JR.

Oncotarget. 2017 Feb 28;8(9):14941-14956. doi: 10.18632/oncotarget.14784.

18.

Ribosomal Proteins Rpl22 and Rpl22l1 Control Morphogenesis by Regulating Pre-mRNA Splicing.

Zhang Y, O'Leary MN, Peri S, Wang M, Zha J, Melov S, Kappes DJ, Feng Q, Rhodes J, Amieux PS, Morris DR, Kennedy BK, Wiest DL.

Cell Rep. 2017 Jan 10;18(2):545-556. doi: 10.1016/j.celrep.2016.12.034.

19.

JUN is a key transcriptional regulator of the unfolded protein response in acute myeloid leukemia.

Zhou C, Martinez E, Di Marcantonio D, Solanki-Patel N, Aghayev T, Peri S, Ferraro F, Skorski T, Scholl C, Fröhling S, Balachandran S, Wiest DL, Sykes SM.

Leukemia. 2017 May;31(5):1196-1205. doi: 10.1038/leu.2016.329. Epub 2016 Nov 14.

20.

Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation.

Peri S, Caretti E, Tricarico R, Devarajan K, Cheung M, Sementino E, Menges CW, Nicolas E, Vanderveer LA, Howard S, Conrad P, Crowell JA, Campbell KS, Ross EA, Godwin AK, Yeung AT, Clapper ML, Uzzo RG, Henske EP, Ricketts CJ, Vocke CD, Linehan WM, Testa JR, Bellacosa A, Kopelovich L, Knudson AG.

Oncotarget. 2017 Mar 14;8(11):17628-17642. doi: 10.18632/oncotarget.12192.

21.

Evaluation of Abbreviated Impactor Measurements (AIM) and Efficient Data Analysis (EDA) for Dry Powder Inhalers (DPIs) Against the Full-Resolution Next Generation Impactor (NGI).

Mohan M, Lee S, Guo C, Peri SP, Doub WH.

AAPS PharmSciTech. 2017 Jul;18(5):1585-1594. doi: 10.1208/s12249-016-0625-9. Epub 2016 Sep 13.

PMID:
27624069
22.

HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant.

Mason WS, Gill US, Litwin S, Zhou Y, Peri S, Pop O, Hong ML, Naik S, Quaglia A, Bertoletti A, Kennedy PT.

Gastroenterology. 2016 Nov;151(5):986-998.e4. doi: 10.1053/j.gastro.2016.07.012. Epub 2016 Jul 22.

PMID:
27453547
23.

The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin.

Wang Y, Bernhardy AJ, Cruz C, Krais JJ, Nacson J, Nicolas E, Peri S, van der Gulden H, van der Heijden I, O'Brien SW, Zhang Y, Harrell MI, Johnson SF, Candido Dos Reis FJ, Pharoah PD, Karlan B, Gourley C, Lambrechts D, Chenevix-Trench G, Olsson H, Benitez JJ, Greene MH, Gore M, Nussbaum R, Sadetzki S, Gayther SA, Kjaer SK; kConFab Investigators, D'Andrea AD, Shapiro GI, Wiest DL, Connolly DC, Daly MB, Swisher EM, Bouwman P, Jonkers J, Balmaña J, Serra V, Johnson N.

Cancer Res. 2016 May 1;76(9):2778-90. doi: 10.1158/0008-5472.CAN-16-0186.

24.

Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck.

Beck TN, Kaczmar J, Handorf E, Nikonova A, Dubyk C, Peri S, Lango M, Ridge JA, Serebriiskii IG, Burtness B, Golemis EA, Mehra R.

Oncotarget. 2015 Aug 7;6(22):18863-74.

25.

Noncanonical mode of ERK action controls alternative αβ and γδ T cell lineage fates.

Lee SY, Coffey F, Fahl SP, Peri S, Rhodes M, Cai KQ, Carleton M, Hedrick SM, Fehling HJ, Zúñiga-Pflücker JC, Kappes DJ, Wiest DL.

Immunity. 2014 Dec 18;41(6):934-46. doi: 10.1016/j.immuni.2014.10.021. Epub 2014 Nov 28.

26.

Cellular oxidative stress response controls the antiviral and apoptotic programs in dengue virus-infected dendritic cells.

Olagnier D, Peri S, Steel C, van Montfoort N, Chiang C, Beljanski V, Slifker M, He Z, Nichols CN, Lin R, Balachandran S, Hiscott J.

PLoS Pathog. 2014 Dec 18;10(12):e1004566. doi: 10.1371/journal.ppat.1004566. eCollection 2014 Dec.

27.

Surface segregation driven by molecular architecture asymmetry in polymer blends.

Lee JS, Lee NH, Peri S, Foster MD, Majkrzak CF, Hu R, Wu DT.

Phys Rev Lett. 2014 Nov 28;113(22):225702. Epub 2014 Nov 26.

PMID:
25494077
28.

Pharmacological profiling of kinase dependency in cell lines across triple-negative breast cancer subtypes.

Fink LS, Beatty A, Devarajan K, Peri S, Peterson JR.

Mol Cancer Ther. 2015 Jan;14(1):298-306. doi: 10.1158/1535-7163.MCT-14-0529. Epub 2014 Oct 24.

29.

Randomized, double-blind, placebo-controlled clinical trial on the efficacy of 0.5% indomethacin eye drops in uveitic macular edema.

Allegri P, Murialdo U, Peri S, Carniglia R, Crivelli MG, Compiano S, Autuori S, Mastromarino A, Zurria M, Marrazzo G.

Invest Ophthalmol Vis Sci. 2014 Mar 10;55(3):1463-70. doi: 10.1167/iovs.13-13202.

PMID:
24519421
30.

Meta-analysis identifies NF-κB as a therapeutic target in renal cancer.

Peri S, Devarajan K, Yang DH, Knudson AG, Balachandran S.

PLoS One. 2013 Oct 7;8(10):e76746. doi: 10.1371/journal.pone.0076746. eCollection 2013.

31.

Whole exome sequence analysis of serous borderline tumors of the ovary.

Boyd J, Luo B, Peri S, Wirchansky B, Hughes L, Forsythe C, Wu H.

Gynecol Oncol. 2013 Sep;130(3):560-4. doi: 10.1016/j.ygyno.2013.06.007. Epub 2013 Jun 14.

32.

NF-κB inhibition by bortezomib permits IFN-γ-activated RIP1 kinase-dependent necrosis in renal cell carcinoma.

Thapa RJ, Chen P, Cheung M, Nogusa S, Pei J, Peri S, Testa JR, Balachandran S.

Mol Cancer Ther. 2013 Aug;12(8):1568-78. doi: 10.1158/1535-7163.MCT-12-1010. Epub 2013 May 8.

33.

Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity.

Goulet ML, Olagnier D, Xu Z, Paz S, Belgnaoui SM, Lafferty EI, Janelle V, Arguello M, Paquet M, Ghneim K, Richards S, Smith A, Wilkinson P, Cameron M, Kalinke U, Qureshi S, Lamarre A, Haddad EK, Sekaly RP, Peri S, Balachandran S, Lin R, Hiscott J.

PLoS Pathog. 2013;9(4):e1003298. doi: 10.1371/journal.ppat.1003298. Epub 2013 Apr 25. Erratum in: PLoS Pathog. 2013 Aug 8;9(8):.

34.

Anti-CD70 immunocytokines for exploitation of interferon-γ-induced RIP1-dependent necrosis in renal cell carcinoma.

Chen P, Nogusa S, Thapa RJ, Shaller C, Simmons H, Peri S, Adams GP, Balachandran S.

PLoS One. 2013 Apr 17;8(4):e61446. doi: 10.1371/journal.pone.0061446. Print 2013.

35.

Manipulation of polymer/polymer interface width from nonequilibrium deposition.

Yu W, Peri SR, Akgun B, Foster MD.

ACS Appl Mater Interfaces. 2013 Apr 24;5(8):2976-84. doi: 10.1021/am3022587. Epub 2013 Apr 5.

PMID:
23560512
36.

The challenge of cholestatic pruritus.

Bolier AR, Peri S, Oude Elferink RP, Beuers U.

Acta Gastroenterol Belg. 2012 Dec;75(4):399-404. Review.

PMID:
23402082
37.

Serum iron profile and ELISA-based detection of antibodies against the iron-regulated protein HupB of Mycobacterium tuberculosis in TB patients and household contacts in Hyderabad (Andhra Pradesh), India.

Sivakolundu S, Mannela UD, Jain S, Srikantam A, Peri S, Pandey SD, Sritharan M.

Trans R Soc Trop Med Hyg. 2013 Jan;107(1):43-50. doi: 10.1093/trstmh/trs005. Epub 2012 Oct 19.

PMID:
23222944
38.

Defining the genomic signature of the parous breast.

Peri S, de Cicco RL, Santucci-Pereira J, Slifker M, Ross EA, Russo IH, Russo PA, Arslan AA, Belitskaya-Lévy I, Zeleniuch-Jacquotte A, Bordas P, Lenner P, Åhman J, Afanasyeva Y, Johansson R, Sheriff F, Hallmans G, Toniolo P, Russo J.

BMC Med Genomics. 2012 Oct 11;5:46. doi: 10.1186/1755-8794-5-46.

39.

CD45-deficient severe combined immunodeficiency caused by uniparental disomy.

Roberts JL, Buckley RH, Luo B, Pei J, Lapidus A, Peri S, Wei Q, Shin J, Parrott RE, Dunbrack RL Jr, Testa JR, Zhong XP, Wiest DL.

Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10456-61. doi: 10.1073/pnas.1202249109. Epub 2012 Jun 11.

40.

The timing of death in patients with tuberculosis who die during anti-tuberculosis treatment in Andhra Pradesh, South India.

Jonnalagada S, Harries AD, Zachariah R, Satyanarayana S, Tetali S, Keshav Chander G, Rao S, Rao R, Peri S, Anchala R, Kannuri NK.

BMC Public Health. 2011 Dec 13;11:921. doi: 10.1186/1471-2458-11-921.

41.

Pregnancy-induced chromatin remodeling in the breast of postmenopausal women.

Russo J, Santucci-Pereira J, de Cicco RL, Sheriff F, Russo PA, Peri S, Slifker M, Ross E, Mello ML, Vidal BC, Belitskaya-Lévy I, Arslan A, Zeleniuch-Jacquotte A, Bordas P, Lenner P, Ahman J, Afanasyeva Y, Hallmans G, Toniolo P, Russo IH.

Int J Cancer. 2012 Sep 1;131(5):1059-70. doi: 10.1002/ijc.27323. Epub 2012 Jan 3.

42.

Control of interface nanoscale structure created by plasma-enhanced chemical vapor deposition.

Peri SR, Akgun B, Satija SK, Jiang H, Enlow J, Bunning TJ, Foster MD.

ACS Appl Mater Interfaces. 2011 Sep;3(9):3375-83. doi: 10.1021/am200543x. Epub 2011 Aug 29.

PMID:
21875044
43.

Characterization of a genomic signature of pregnancy identified in the breast.

Belitskaya-Lévy I, Zeleniuch-Jacquotte A, Russo J, Russo IH, Bordás P, Ahman J, Afanasyeva Y, Johansson R, Lenner P, Li X, de Cicco RL, Peri S, Ross E, Russo PA, Santucci-Pereira J, Sheriff FS, Slifker M, Hallmans G, Toniolo P, Arslan AA.

Cancer Prev Res (Phila). 2011 Sep;4(9):1457-64. doi: 10.1158/1940-6207.CAPR-11-0021. Epub 2011 May 27.

44.

Treatment end point determinants for pulmonary tuberculosis: human resistin as a surrogate biomarker.

Ehtesham NZ, Nasiruddin M, Alvi A, Kumar BK, Ahmed N, Peri S, Murthy KJ, Hasnain SE.

Tuberculosis (Edinb). 2011 Jul;91(4):293-9. doi: 10.1016/j.tube.2011.04.007. Epub 2011 May 24.

PMID:
21606003
45.

Potential of mean force for separation of the repeating units in cellulose and hemicellulose.

Peri S, Karim MN, Khare R.

Carbohydr Res. 2011 May 1;346(6):867-71. doi: 10.1016/j.carres.2011.01.008. Epub 2011 Jan 15.

PMID:
21388614
46.

ALA-D and ALA-D reactivated as biomarkers of lead contamination in the fish Prochilodus lineatus.

Lombardi PE, Peri SI, Verrengia Guerrero NR.

Ecotoxicol Environ Saf. 2010 Oct;73(7):1704-11. doi: 10.1016/j.ecoenv.2010.06.005.

PMID:
20599271
47.

Early changes in gene expression induced by tobacco smoke: Evidence for the importance of estrogen within lung tissue.

Meireles SI, Esteves GH, Hirata R Jr, Peri S, Devarajan K, Slifker M, Mosier SL, Peng J, Vadhanam MV, Hurst HE, Neves EJ, Reis LF, Gairola CG, Gupta RC, Clapper ML.

Cancer Prev Res (Phila). 2010 Jun;3(6):707-17. doi: 10.1158/1940-6207.CAPR-09-0162. Epub 2010 Jun 1.

48.

Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations.

Bellacosa A, Godwin AK, Peri S, Devarajan K, Caretti E, Vanderveer L, Bove B, Slater C, Zhou Y, Daly M, Howard S, Campbell KS, Nicolas E, Yeung AT, Clapper ML, Crowell JA, Lynch HT, Ross E, Kopelovich L, Knudson AG.

Cancer Prev Res (Phila). 2010 Jan;3(1):48-61. doi: 10.1158/1940-6207.CAPR-09-0078.

49.

Overexpression of periostin and lumican in esophageal squamous cell carcinoma.

Kashyap MK, Marimuthu A, Peri S, Kumar GS, Jacob HK, Prasad TS, Mahmood R, Kumar KV, Kumar MV, Meltzer SJ, Montgomery EA, Kumar RV, Pandey A.

Cancers (Basel). 2010 Mar 1;2(1):133-42. doi: 10.3390/cancers2010133.

50.

Detection of clonally expanded hepatocytes in chimpanzees with chronic hepatitis B virus infection.

Mason WS, Low HC, Xu C, Aldrich CE, Scougall CA, Grosse A, Clouston A, Chavez D, Litwin S, Peri S, Jilbert AR, Lanford RE.

J Virol. 2009 Sep;83(17):8396-408. doi: 10.1128/JVI.00700-09. Epub 2009 Jun 17.

Supplemental Content

Support Center